News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arterial Remodeling Technologies Receives Regulatory Approval to Begin First-In-Man "ARTDIVA" Clinical Trial With its Next-generation Bioresorbable Stent


5/15/2012 10:53:21 AM

PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) reported today that it has received regulatory approval in Europe to begin its First-In-Man “ARTDIVA” (Arterial Remodeling Transient DIsmantling Vascular Angioplasty) clinical trial next month at five medical centers. ART’s in vivo data strongly suggest that its next-generation bioresorbable stent is designed to promote positive arterial remodeling.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES